Compare PRSO & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRSO | EVGN |
|---|---|---|
| Founded | 2008 | 1999 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Semiconductors | Agricultural Chemicals |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.4M | 11.1M |
| IPO Year | 2000 | 2013 |
| Metric | PRSO | EVGN |
|---|---|---|
| Price | $0.67 | $0.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $3.00 | ★ $3.50 |
| AVG Volume (30 Days) | 300.9K | ★ 347.8K |
| Earning Date | 05-11-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 81.23 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $14,573,000.00 | N/A |
| Revenue This Year | $18.48 | N/A |
| Revenue Next Year | $53.57 | $73.33 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 5.99 | N/A |
| 52 Week Low | $0.58 | $0.37 |
| 52 Week High | $2.37 | $1.50 |
| Indicator | PRSO | EVGN |
|---|---|---|
| Relative Strength Index (RSI) | 41.90 | 49.37 |
| Support Level | $0.58 | $0.52 |
| Resistance Level | $0.94 | $0.84 |
| Average True Range (ATR) | 0.06 | 0.09 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 47.98 | 34.43 |
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices, and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz to 300 GHz. Geographically, the company generates revenue from the United States, Hong Kong, Taiwan, Europe, and the Rest of the World.
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.